Inhibition of pituitary-adrenal secretion by a corticotropin releasing hormone antagonist in humans

Molecular Psychiatry

Volumn 1, Issue 4, 1996, Pages 320-324

  Baram, T Z ^a,c   Mitchell, W G ^b   Haden, E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UCL   (United States)

Author keywords

ACTH; Cortisol; CRF; Hypothalamo pituitary adrenal; Neuropeptide; Receptor

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING HORMONE (9 41); CORTICOTROPIN RELEASING HORMONE (9-41); HORMONE ANTAGONIST; HYDROCORTISONE; PEPTIDE FRAGMENT;

ADULT; ARTICLE; BLOOD; CIRCADIAN RHYTHM; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; PHASE 1 CLINICAL TRIAL; PHYSIOLOGY; SECRETION;

ADRENOCORTICOTROPIC HORMONE; ADULT; CIRCADIAN RHYTHM; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HORMONE ANTAGONISTS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PEPTIDE FRAGMENTS; PITUITARY-ADRENAL SYSTEM;

EID: 0030229891     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson L, Bilezikjian L, Bloom F, Rivier J. Chemical and biological characterization of corticotropin releasing factor. Rec Prog Horm Res 1983; 39: 245-270.
2. Sawchenko PE, Imaki T, Potter E, Kovacs K, Imaki J, Vale W. The functional neuroanatomy of corticotropin releasing factor. CIBA Foundation Symp 1993; 172: 5-21.
3. Tsigos C, Chrousos GP. Physiology of the hypothalamic pituitary adrenal axis in health and dysregulation in psychiatric and autoimmune disorders. Endocrinol Metabol Clin North Am 1994; 23: 451-466.
4. Makino S, Smith MA, Gold PW. Increased expression of CRH and vasopressin mRNA in the hypothalamic PVN during repeated stress: association with reduction of glucocorticoid receptor mRNA levels, Endocrinology 1995; 136: 3299-3309.
5. Fox EA, Gruol DL. CRF suppresses the afterhyperpolarization in cerebellar Purkinje neurons. Neurosci Lett 1993; 49: 103-107.
6. Ehlers CL, Henriksen SJ, Wang M, Rivier J, Vale W, Bloom FE. Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res 1983; 278: 332-336.
7. Baram TZ, Schultz L. CRH is a rapid and potent convulsant in the infant rat. Dev Brain Res 1991; 61: 97-101.
8. Rainnie DG, Fernhout BJ, Shinnick-Gallagher P. Differential actions of corticotropin releasing factor on basolateral and central amygdaloid neurons in vitro. J Pharmacol Exper Therap 1992; 263: 846-858.
9. Curtis AL, Pavcovich D, Grigoriadis DE, Valentino RJ. Previous stress alters corticotropin releasing factor neurotransmission in the locus ceruleus. Neuroscience 1995; 65: 541-550.
10. Young WS III. Distribution and regulation of CRF-mRNA in brain using in situ hybridization histochemistry. In: De Souza EB, Nemeroff CB (eds). Corticotropin Releasing Factor: Basic and Clinical Studies of a Neuropeptide. CRC: Boca Raton, 1990, pp 213-220.
11. De Souza EB, Kuhar MJ. Corticotropin-releasing factor receptors: autoradiographic identification. In: Martin JB, Barchas JD (eds). Neuropeptides in Neurologic and Psychiatric Disease. Raven Press: New York, 1986, pp 179-198.
12. Wong ML, Licinio J, Gold PW. Localization of CRH receptor mRNA in adult rat by in situ hybridization. Endocrinology 1994; 135: 2275-2278.
13. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale WW. Distribution of CRF-receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci 1994; 91: 8777-8781.
14. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T. Cloning and characterization of functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci 1995; 92: 836-840.
15. Bissette G, Reynolds GP, Kilts CD, Widerlov E, Nemeroff CB. Corticotropin releasing factor like immunoreactivity in senile dementia of the Alzheimer type. JAMA 1985; 254: 3067-3069.
16. Behan DP, Heinrichs SC, Troncoso JC, Liu XJ, Kawas CH, Ling N, De Souza EB. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature 1995; 378: 284-287.
17. Nemeroff CB. New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin releasing factor. Neuropsychopharmacology 1992; 6: 69-75.
18. Baram TZ. Pathophysiology of massive infantile spasms: perspective on the role of the brain adrenal axis. Ann Neurol 1993; 33: 231-237.
19. Lightman SL. Corticotropin releasing factor: from stress to cognition. Nature 1995; 378: 233-234.
20. Rivier J, Rivier C, Vale W. Synthetic competitive antagonists of corticotropin releasing factor: effect on ACTH secretion in the rat. Science 1984; 224: 889-891.
21. Nieman LK, Chrousos GP, Oldfield EH. The ovine corticotropin releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing disease. Ann Int Med 1986; 105: 862-867.
22. Nink M, Salomon E, Coutinho M, Treese N, Bernhard G, Krause U, Beyer J, Lehnert H. Corticotropin releasing hormone is a respiratory stimulant in humans. Life Sci 1994; 23: 1793-1799.
23. Kubler A, Rothacher G, Knappertz VA, Kramer G, Nink M, Beyer J, Lehnert H. Intra- and extracerebral blood flow changes and flushing after intravenous injection of human corticotropin releasing hormone. Clin Invest 1994; 72: 331-336.
24. Summary of clinical studies. Lamotrigine package insert, Glaxo-Wellcome, October 1995.
25. Licinio J, Wong K-L, Gold PW. The hypothalamic-pituitary-adrenal axis in anorexia nervosa. Psychiat Res 1996; 62: 75-83.